Exane BNP Paribas Downgrades Novartis (NVS) to Neutral
Tweet
Share
E-mailGet Alerts NVS Hot Sheet
Price: $93.08 -0.13%
Rating Summary:
6 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 19
Rating Summary:
6 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 19
Join SI Premium – FREE
Exane BNP Paribas downgraded Novartis (NYSE: NVS) from Outperform to Neutral.
For more ratings news on Novartis click here and for the rating history of Novartis click here.
Shares of Novartis closed at $56.37 yesterday.
For more ratings news on Novartis click here and for the rating history of Novartis click here.
Shares of Novartis closed at $56.37 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- New Novartis (NVS) Fabhalta data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgAN
- Raymond James Downgrades Synovus Financial (SNV) to Market Perform
- Nomura/Instinet Downgrades ABB India (ABB:IN) to Neutral
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
